"description","identifier","uuid:ID","label","id","name","text","instanceType"
"The study age criterion","1","2e471603-b55f-4e4e-b7df-acf09eeb9b59","","EligibilityCriteria_1","Age Criteria","Subjects shall be between [min_age] and [max_age]","ELIGIBILITY_CRITERIA"
"The study population criterion","2","66fb530f-0b0b-4a7b-a9ab-1badc870281b","","EligibilityCriteria_2","Pop Criteria","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)","ELIGIBILITY_CRITERIA"
"The study diagnosis criterion","3","76a51433-21a2-467b-939b-89a63f684fa9","","EligibilityCriteria_3","Diag Criteria","[Activity1] score of 10 to 23","ELIGIBILITY_CRITERIA"
"The previous xanomeline TTS criterion","9","3aa24100-41d7-4392-8333-731a4d2ce20b","","EligibilityCriteria_4","Previous Criteria","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline.","ELIGIBILITY_CRITERIA"
